Topics-in-Focus program

Promising results in trials with non-chemotherapy treatments for Leukemias to be presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013

What is new? Current investigations are aimed at evaluating the use of monoclonal antibodies (mAB). These mABs bind to specific molecules (antigens) found on leukemic cells. This results in immune destruction of the leukemic cells.

Burnout - it doesn't just happen to someone else

Burnout - it doesn't just happen to someone else

By Dr. med.

Evidence and policy to ensure good clinical practice

Interview with Vinay Prasad MD MPH by Heiko Becker MD, on behalf of YoungEHA

Leaders in the field that have the potential to make a difference, that challenge the way we are doing things, who push our perspective out of our…

I would like to renew my EHA membership

Renew your EHA membership to ensure that you will be able continue enjoying your membership benefits all year round.

I would like to be an EHA Member

Our members come from all corners of the world – from a University Hospitals in India to research companies in Germany.

How to apply for an EHA Research Grant

On this page, we explain all of the actions you'll need to take when submitting a grant application. You can also get a basic overview of the process in our EHA Research Grants diagram.

I would like to be an EHA Guest

Would you like to connect with EHA, but you do not feel ready to fully commit yet? By becoming an EHA Guest, you will enjoy:

Free access to the European Hematology Curriculum
Limited access the EHA Campus
Receive EHA Newsflashes to keep you informed…

Program

All session times are in Eastern European Time (EET).

More than science: the European Affairs program at EHA2023

To develop and administer safe, innovative and effective treatments for patients with blood diseases, hematologists need an effective and enabling regulatory environment.